TORONTO, Jan. 5, 2018 /CNW/ - Syncordia Technologies
and Healthcare Solutions, Corp. (TSXV: SYN) ("Syncordia") is
pleased to provide an update on its refinancing efforts with the
signing of a debt term sheet for up to $16.5million.
Terms of the debt term sheet will be finalized pending final
diligence, which will take place over the coming weeks and months.
The debt term sheet has a four (4) year term and will involve a
mezzanine level coupon with accompanying warrants. Final terms will
be established based on operational and financial diligence and the
final capital structure, as Syncordia plans to compliment this term
sheet with an equity round of financing. Completion of the new debt
structure will also be subject to customary approvals including
lender approval, final documentation and TSX Venture approval.
About Syncordia Technologies and Healthcare Solutions, Corp.
dba Syncordia Software
Syncordia Software has a portfolio investment management
approach to its growth by partnering with strong
companies with a focus on healthcare. We like
to partner with well run businesses that have established free
cash flow and a strong propensity to growth with
meaningful easy to use software and IT service solutions.
We are a software and information technology services company with
a focus on healthcare. We are focused on using our proprietary
software suite as an accelerator for growth. Our growth strategy is
to acquire healthcare oriented software and information technology
service companies with great teams and improve their profitability
by increasing revenues and improving operating efficiencies working
with the local management teams. Syncordia will leverage
proprietary software to manage scale, drive better customer
experiences and enhance margins while driving a competitive
sustainable profile.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Forward Looking Statements
Certain statements herein may be "forward looking" statements
that involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or
achievements of Syncordia or the industry to be materially
different from any future results, performance or achievements
expressed or implied by such forward-looking statements. Forward
looking statements involve significant risks and uncertainties,
should not be read as guarantees with respect to any potential debt
and/or equity offering or of future performance or results, and
will not necessarily be accurate indications of whether such
transactions will be consummated or results will be achieved. A
number of factors could cause such transactions to not be completed
or actual results to vary significantly from the results discussed
in the forward-looking statements. These forward-looking statements
reflect current assumptions and expectations regarding future
events and operating performance and are made as of the date hereof
and we assume no obligation, except as required by law, to update
any forward-looking statements to reflect new events or
circumstances.
SOURCE Syncordia Technologies and Healthcare Solutions,
Corp.